Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Interested in joining our team? Read more here.

Department of Bioethics and Decision Sciences

About the department

The Department of Bioethics and Decision Sciences is part of the Geisinger College of Health Sciences, the research and education arm of Geisinger. It is also deeply embedded in the 30,000-employee integrated health system, whose 10 hospital campuses and 100+ clinics serve 6.7 million Pennsylvanians and 500,000 health plan members. The department serves multiple functions spanning research, education, clinical and research ethics consultation, policy development, patient safety and quality improvement. 

Much of this work involves helping people — patients, caregivers, research participants, researchers and organizational leaders — make better decisions by defining options, identifying stakeholder preferences and values, and weighing trade-offs. The department’s innovation is bringing together faculty and staff from a wide range of disciplines and fields comprising bioethics (which focuses on defining and analyzing what decisions people should make) and the decision sciences (which focus on the scientific study of how people actually make decisions), including law, philosophy, religious studies, bioethics, cognitive science, social psychology, behavioral economics, medicine, nursing, clinical social work and public health. 

Working independently and collaboratively with internal and external colleagues, the department has two intertwined objectives: (1) to better understand how people make decisions related to healthcare, science and innovation; and (2) to help people make “better” decisions — those that are more ethical, more aligned with evidence and with their own considered judgments or their patients’ preferences, less influenced by biases of various kinds, and that serve the Geisinger mission of making better health easier. 

Learn more about the department’s functions:


Although department researchers also pursue more traditional research in their respective fields of bioethics and decision sciences, the department uniquely brings them together to collaboratively investigate questions at their intersection, especially in the domains of health, science and innovation. Researchers in the department use a wide range of quantitative and qualitative methods, and enjoy access to over 25 years of electronic health record and claims data, and over 300,000 consented participants in the MyCode Community Health Initiative biobank. They investigate questions such as:

  • When and why do people exhibit aversion to, or appreciation of, the use of “algorithms” and other AI tools in decision-making?
  • How do people incorporate beliefs, misbeliefs, and concerns about data privacy into their decisions about healthcare and research?
  • How do people (mis)understand genetic information, and how is this information best presented?
  • Does the disclosure to adolescents of genetic variants associated with adult-onset disease place them at risk of psychological harm?
  • When and why do people prefer to implement untested practices and policies instead of subjecting them to A/B testing, and how can we intervene to reduce this bias to advance a learning health system? 
  • How does moral distress affect the quality of clinical decisions? How does moral distress affect the functioning of healthcare teams?
  • Do clinicians neglect important information when interpreting diagnostic test results, and if so, how can the incidence of such biases be reduced?
  • Are laypeople and clinicians rational when making decisions about rationing healthcare?
  • When and why are some people hesitant to be vaccinated and how can that be addressed?
  • What kinds of “nudges” are acceptable to stakeholders, when and why?

Departmental research has been funded by several divisions of the National Institutes of Health (NIH), including the National Institute on Aging (NIA), the National Human Genome Research Institute (NHGRI), the National Cancer Institute (NCI), the National Center for Advancing Translational Sciences (NCATS), and the Office of the Director; the U.S. Food and Drug Administration (FDA); the National Science Foundation (NSF); the Patient-Centered Outcomes Research Institute (PCORI); the National Bureau of Economic Research (NBER) Roybal Center for Behavior Change in Health; the Russell Sage Foundation (RSF); the JPB Foundation; the Robert Wood Johnson Foundation (RWJF); Open Philanthropy; and Riksbankens Jubileumsfond, a Swedish foundation dedicated to supporting the humanities and social sciences. 

Department members have published their research in leading peer-reviewed journals in several fields, including the New England Journal of Medicine, Science, Nature, Proceedings of the National Academy of Sciences (PNAS), Health Affairs, Nature Medicine, Nature Genetics, American Journal of Bioethics (AJOB), Hastings Center Report, Journal of Law, Medicine & Ethics, JAMA Network Open, Circulation, Genetics in Medicine, Clinical Trials, Perspectives on Psychological Science, Trends in Cognitive Sciences, Advances in Methods and Practices in Psychological Science (AMPPS), as well as the Behavioral Economics Guide and in edited volumes from Routledge, Cambridge University Press, MIT Press, and other publishers. Members have also translated their research for the public, writing for popular media outlets such as The New York Times, The Wall Street Journal, The Washington Post, Los Angeles Times, Slate, the Chronicle of Higher Education and Wired.

Department members present their work at national and international conferences, including the American Society for Bioethics and Humanities (ASBH), the American Society of Human Genetics (ASHG), ELSI Congress, Public Responsibility in Medicine and Research (PRIM&R), the International Conference on Computational Social Science (IC2S2), the Conference on Digital Experimentation @ MIT (CODE), the ASLME Health Law Professors Conference, the Penn Medicine Nudges in Health Care Symposium, the Penn Behavioral Science & Health Symposium, as well as numerous invited talks at institutions in the U.S., Canada, Europe and Australia. 

Finally, members of the department have served on several boards and commissions, including the President’s Council on Bioethics, the Healthcare Ethics Consultant Certification Commission, an American Psychology Association blue ribbon commission, National Academies study committees, task forces of the American Society for Bioethics and Humanities, NIH and NSF review panels, multiple IRBs and journal editorial or advisory boards.

Examples of our work:


The department is part of the Geisinger College of Health Sciences, which includes (in addition to its Research Institute) the Geisinger Commonwealth School of Medicine, the Geisinger School of Nursing and the Geisinger School of Graduate Education (which includes a masters program in Biomedical Sciences and graduate certificates in Pharmacy Systems Science and Healthcare Leadership). 

Department faculty are members of Geisinger’s Academy of Educators and participate in graduate and continuing education in (primarily clinical) ethics and the decision sciences. This includes producing an annual spring bioethics symposium for medical residents and fellows and developing and delivering program-specific educational content in several of Geisinger’s numerous medical and nurse fellowship and residency programs. 

The Department also develops ethics quality advisories (EQAs) — brief, targeted, widely-distributed communiques about recurring themes seen in clinical ethics consultations — and sometimes develops targeted educational initiatives around these topics for delivery to groups of clinicians.

Finally, researchers in the department contribute to education by mentoring junior faculty, postdoctoral fellows, predoctoral fellows, and undergraduate and medical student interns interested in research, by guest lecturing in undergraduate and graduate classes across the country, and by serving as faculty at continuing professional education conferences such as Public Responsibility in Medicine and Research (PRIM&R).

Ethics consultation

Members of the department staff two advice and consultation services in clinical and research ethics, respectively, and oversee a network of hospital ethics committees.

Clinical Ethics Advice and Consultation Service (CEACS): The CEACS is staffed by department members who are certified healthcare ethics consultants. It is available 24 hours a day, seven days a week, free of charge, to any Geisinger patient, patient family member or loved one, or healthcare team member. Ethics consultants help navigate the ethical challenges of uncertainty and conflict inherent in clinical decision-making and care. Request a consult by TigerText (search for “Clinical Ethics Advice and Consultation Service”) or by calling 570-214-2400; the ethicist on call will respond as soon as possible.

Research Ethics Advice and Consultation Service (REACS): The REACS is staffed by department members with expertise in the responsible conduct of research. It is available, free of charge, to investigators and other research team members as well as to IRB members and staff. REACS provides members of the research community with timely consultation on ethical issues in the design and conduct of research (including but not limited to research involving human participants), quality improvement, and innovation. Learn more about the consultation service.

Hospital ethics committees: Members of the department participate in and oversee Geisinger’s five hospital ethics committees. Each committee is engaged in policy development, review, and revision; quality oversight of clinical ethics advice and consultation; and clinical ethics education. 


Members of the department are responsible for the development, review and (as appropriate) revision of several system policies and guidelines, and they participate in the development and revision of many more. These policies span the range of bioethics subfields (e.g., clinical ethics, research ethics, public health ethics, the ethical, legal and social implications (ELSI) of emerging technologies) and include policies regarding: 

  • Surrogate decision-making
  • Assessing decisional capacity
  • Shared decision-making
  • Advanced care planning/advance directives
  • Unrepresented patients
  • Crisis standards of care 
  • Allocation of scarce resources 
  • Employee vaccine mandate exemptions
  • Trial prioritization
  • Data sharing 
  • Appropriate use of MyCode Community Health Initiative data and engagement of participants
  • Appropriate use of health AI
  • Integrative medicine
  • Program evaluation
Safety and quality

Members of the department lead or participate in a range of initiatives aimed at improving the safety and quality of the healthcare environment for both Geisinger’s patients and its employees.

MyCareChoices: Department faculty serve on the steering committee for this broad-based initiative to improve the quality of decision making and care for patients grappling with serious advanced illness by (1) increasing the uptake of advance care planning and (2) enhancing the communication skills of clinicians for person-centered, shared decision making. Department faculty are also among the core faculty for Shared Decision Making in Serious Illness, the communication skills-focused component of MyCareChoices.

Patient safety: Department faculty serve on the steering committee for Communication and Optimal Response (CANDOR), the AHRQ-developed framework and process for improving organizational responses to adverse events and errors that Geisinger adopted in 2018. In collaboration with the Healthcare Communications Program, Department faculty lead the education and training for senior clinicians and clinical leaders in the “ethical, effective disclosure of events and errors” workshop, a key programmatic element of CANDOR.

Patient/Surrogate misconduct: Department faculty co-lead this system-wide initiative to develop more effective responses to the challenges of misconduct on the part of patients and their loved ones or surrogates. Faculty have been instrumental in developing guidelines to inform the behavior and responses of frontline clinicians who are confronted with misconduct, and are now working to implement these guidelines across the system.

Organizational culture — professionalism, psychological safety and just culture: Department faculty collaborated with faculty from the Center for Professionalism and Well-Being to develop a toolkit of resources for improving aspects of the system’s organizational culture, including workshops on: giving and receiving effective feedback; resolving and transforming conflict; and fostering psychological safety. Faculty also collaborate with residency and fellowship program directors to develop and offer education and trainings designed to advance professionalism on the part of learners.


  • Michelle N. Meyer, PhD, JD, Associate Professor, Chair and Chief Bioethics Officer
  • Christopher F. Chabris, PhD, Professor and Director of Decision Sciences
  • F. Daniel Davis, PhD, HEC-C, Professor and Associate Chief, Clinical Ethics and Healthcare Communications

Faculty and staff:

  • Sharon Gray, MA, RN, HEC-C, Senior Clinical Ethicist
  • Shannon Getchey, Senior Administrative Assistant
  • Daniel J. Hoegen, LSW, MS, HEC-C, Clinical Ethicist
  • Tessy A. Thomas, DO, MBioethics, Assistant Professor
  • Carroll Walter, MA, MPH, CPH, Project Manager

Predoctoral and Postdoctoral fellows:

  • Rebecca Mestcheckin, BS, Predoctoral Fellow
  • Randi Vogt, PhD, Postdoctoral Fellow

Department affiliates:

  • Amir Goren, PhD, Program Director, Behavioral Insights Team, Steele Institute for Health Innovation
  • Gail Rosenbaum, PhD, Staff Scientist, Behavioral Insights Team, Steele Institute for Health Innovation